A Randomised, Double-blind, Placebo-controlled Study of the Effect of LIraglutide on Left VEntricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes (The LIVE-study)

Trial Profile

A Randomised, Double-blind, Placebo-controlled Study of the Effect of LIraglutide on Left VEntricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes (The LIVE-study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Chronic heart failure; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms LIVE
  • Most Recent Events

    • 30 Aug 2017 Results of a substudy presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
    • 10 Jun 2017 Biomarkers information updated
    • 28 Oct 2016 Primary endpoint has not been met. (Change in Left ventricular function from visit 1 to week 24, measured by Ecco)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top